211 related articles for article (PubMed ID: 29325322)
21. Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.
Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynaecol Obstet; 2016 Jul; 134(1):49-52. PubMed ID: 27039052
[TBL] [Abstract][Full Text] [Related]
22. Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.
Trillsch F; Mahner S; Woelber L; Vettorazzi E; Reuss A; Ewald-Riegler N; de Gregorio N; Fotopoulou C; Schmalfeldt B; Burges A; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Kommoss F; Hauptmann S; du Bois A
Ann Oncol; 2014 Jul; 25(7):1320-1327. PubMed ID: 24618151
[TBL] [Abstract][Full Text] [Related]
23. Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases.
Li N; Gou J; Li L; Ming X; Hu TW; Li Z
BMC Cancer; 2020 Aug; 20(1):769. PubMed ID: 32807135
[TBL] [Abstract][Full Text] [Related]
24. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
[TBL] [Abstract][Full Text] [Related]
25. Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.
Wang L; Zhong Q; Tang Q; Wang H
Arch Gynecol Obstet; 2022 Oct; 306(4):1177-1183. PubMed ID: 35396974
[TBL] [Abstract][Full Text] [Related]
26. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
27. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer.
Schlaerth AC; Chi DS; Poynor EA; Barakat RR; Brown CL
Int J Gynecol Cancer; 2009 Oct; 19(7):1199-204. PubMed ID: 19823055
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors and fertility outcomes of borderline ovarian tumors after conservative surgery].
Tao T; Cao DY; Yang JX; Shen K; Lang JH; Guo LN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):488-92. PubMed ID: 21050550
[TBL] [Abstract][Full Text] [Related]
30. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factors and reproductive outcomes of borderline ovarian tumors: a review of 186 patients].
Tao T; Cao DY; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Guo LN; Shen K
Zhonghua Yi Xue Za Zhi; 2010 May; 90(19):1304-8. PubMed ID: 20646576
[TBL] [Abstract][Full Text] [Related]
32. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
[TBL] [Abstract][Full Text] [Related]
33. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
[TBL] [Abstract][Full Text] [Related]
34. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
35. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
Borgfeldt C; Iosif C; Måsbäck A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
[TBL] [Abstract][Full Text] [Related]
36. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Trillsch F; Mahner S; Vettorazzi E; Woelber L; Reuss A; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Fotopoulou C; Schmalfeldt B; Burges A; Ewald-Riegler N; de Gregorio N; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Kommoss S; Kommoss F; Hauptmann S; du Bois A
Br J Cancer; 2015 Feb; 112(4):660-6. PubMed ID: 25562434
[TBL] [Abstract][Full Text] [Related]
37. Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant-a Chinese retrospective cohort study among 148 cases.
Yang B; Yu Y; Chen J; Zhang Y; Yin Y; Yu N; Chen G; Zhu S; Huang H; Yuan Y; Ai J; Wang X; Li K
Front Med; 2018 Oct; 12(5):509-517. PubMed ID: 29218679
[TBL] [Abstract][Full Text] [Related]
38. Borderline ovarian tumors: outcomes of fertility sparing surgery.
Ozalp SS; Yalcin OT; Telli E; Oge T; Kabukcuoglu S
Eur J Gynaecol Oncol; 2014; 35(2):154-6. PubMed ID: 24772918
[TBL] [Abstract][Full Text] [Related]
39. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
40. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
Plett H; Ricciardi E; Vacaru V; Ramspott JP; Colombo N; Sehouli J; du Bois A; Garbi A; Richter R; Ataseven B; Aletti G; Braicu E; Heitz F; Portuesi R; Muallem MZ; Dagres T; Parma G; Roser E; Traut A; Multinu F; Harter P
Int J Gynecol Cancer; 2023 May; 33(5):734-740. PubMed ID: 36759002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
